UBS O'Connor’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.96K Hold
181,387
﹤0.01% 222
2025
Q3
$9.72K Hold
181,387
﹤0.01% 262
2025
Q2
$11.8K Hold
181,387
﹤0.01% 347
2025
Q1
$8.98K Hold
181,387
﹤0.01% 308
2024
Q4
$11.1K Hold
181,387
﹤0.01% 393
2024
Q3
$2.19K Sell
181,387
-4,029
-2% -$79 ﹤0.01% 494
2024
Q2
$3.75K Hold
185,416
﹤0.01% 529
2024
Q1
$14.6K Hold
185,416
﹤0.01% 472
2023
Q4
$6.49K Sell
185,416
-1,177
-0.6% -$48 ﹤0.01% 470
2023
Q3
$8.99K Hold
186,593
﹤0.01% 525
2023
Q2
$7.74K Sell
186,593
-6,072
-3% -$328 ﹤0.01% 555
2023
Q1
$16.4K Buy
+192,665
New +$10.7K ﹤0.01% 569
2022
Q4
Sell
-192,665
Closed -$22K 356
2022
Q3
$22K Sell
192,665
-19,287
-9% -$2.79K ﹤0.01% 883
2022
Q2
$33K Buy
+211,952
New +$50K ﹤0.01% 888

Other funds holding TVGNW

UBS O'Connor's TVGNW Position: Q4 2025 in Review

UBS O'Connor held its Tevogen Inc. Warrant (TVGNW) position steady in Q4 2025 at 181,387 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

UBS O'Connor first reported a position in TVGNW in Q2 2022 and has held it in 14 quarters since. The position peaked at $33K in Q2 2022. 31 funds tracked by Wall St. Rank hold TVGNW as of Q4 2025.

  • UBS O'Connor held 181,387 shares of Tevogen Inc. Warrant worth $6.96K as of Q4 2025.
  • UBS O'Connor left its Tevogen Inc. Warrant share count unchanged in Q4 2025.
  • Tevogen Inc. Warrant made up ﹤0.01% of UBS O'Connor's portfolio in Q4 2025, its #222 holding.
  • UBS O'Connor first reported a position in Tevogen Inc. Warrant in Q2 2022 and has held it in 14 quarters since.
  • UBS O'Connor's Tevogen Inc. Warrant position peaked at $33K in Q2 2022.
  • 31 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.